EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis

Jiexiang Yang, Jing Jiang, Jing Wang, Lin Luo iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0332761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jiexiang Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, P.R. China. Hauptthemen laut MEDLINE: Ferroptosis, Tumor Suppressor Protein p53, Osteoarthritis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Luzhou Science and Technology Bureau in 2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ferroptosis is a nonapoptotic form of cell death characterized by lipid peroxidation and intracellular iron accumulation. OA is a prevalent joint disease, and as OA progresses, inflammation or iron overload can induce ferroptosis in chondrocytes. However, research on genes that play important roles in this process remains insufficient.

Methods

In this study, we identified the ferroptosis-related gene SAT1 by analyzing OA-associated GEO datasets. For in vivo experiments, we induced an OA mouse model by transecting the medial meniscus ligament. In vitro , we analyzed the biological functions of SAT1 in ATDC5 cells using Cell Counting Kit-8 (CCK-8), trypan blue staining, Western blot, and detection of ferroptosis-related indicators. Additionally, we explored the mechanisms underlying SAT1’s role in OA progression through immunoblotting, ubiquitination, and acetylation immunoprecipitation experiments.

Results

Bioinformatics analysis revealed a close association between OA and ferroptosis. Our experimental results showed that overexpression of SAT1 effectively induced ferroptosis in ATDC5 cells. Mechanistically, SAT1 promoted p53 stability by downregulating TRIM33, which inhibits p53 acetylation. By suppressing TRIM33 expression, SAT1 enhanced p53 acetylation and stability, thereby increasing ferroptosis and exacerbating OA progression.

Conclusion

In summary, our data indicate that SAT1 is a potential key gene in OA, revealing the crucial role of the SAT1-TRIM33-p53 axis in OA pathogenesis. This axis promotes ferroptosis by enhancing p53 acetylation, suggesting that targeting SAT1 may represent a novel therapeutic strategy for improving OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisTumor Suppressor Protein p53OsteoarthritisAnimalsMiceAcetylationDisease ProgressionHumansChondrocytesCell LineDisease Models, AnimalMaleMice, Inbred C57BL

Substanzen

Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, P.R. China.

ORCID-Profile: Lin Luo

Förderung

  • Key Research and Development Program of Luzhou Science and Technology Bureau in 2022

Zitieren

APA

Yang, J., Jiang, J., Wang, J., & Luo, L. (2025). SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis. PLOS One. https://doi.org/10.1371/journal.pone.0332761

Vancouver

Yang J, Jiang J, Wang J, Luo L. SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis. PLOS One. 2025. doi:10.1371/journal.pone.0332761

BibTeX
@article{Yang2025,
  author = {Yang, Jiexiang and Jiang, Jing and Wang, Jing and Luo, Lin},
  title = {SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0332761}
}
Kostenlos starten →